Noninvasive ventilation and the potential risk of transmission of infection

Singh, Anshul; Sterk, Peter J.

doi:10.1183/09031936.00052208

Cited by 7 publications

(1 citation statement)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…NIV, BPAP, and CPAP are currently listed by the WHO as a high-risk aerosol-generating procedure. NIV accounts for high-dose viral transmission risk to family and carers during the treatment of chronic respiratory diseases, especially obstructive sleep apnea [13][14][15][16][17]. The viral load is comparable in nasal and throat swabs of symptomatic and asymptomatic patients with COVID-19 [17], suggesting that NIV-induced aerosolization of nasopharyngeal secretions from asymptomatic patients may pose similar risks for high-dose viral transmission in households.…”

Section: At Homementioning

confidence: 99%

Management of Aerosol during Noninvasive Ventilation for Patients with Sleep-Disordered Breathing: Important Messages during the COVID-19 Pandemic

et al. 2020

View full text Add to dashboard Cite

With the advent of COVID-19 infection and its rapid spread, preventive strategies are being developed worldwide, besides following the universal infection control guidelines. Prevention of spread through aerosol generation is one of the essential strategies in this regard, particularly for patients with sleep-disordered breathing at home and during hospital admission. Aerosols are produced, at home and in health care facilities, by natural processes and aerosol-generating procedures. To address this impinging problem, aerosol-generating procedures, like non-invasive ventilation (NIV), are to be handled meticulously, which might warrant isolation and sometimes device/interface modifications.

show abstract